APA (7th ed.) Citation

Melissa Basile, Jennifer Polo, Katherine Henthorne, Joan DeCelie-Germana, Susan Galvin, & Janice Wang. (2024). The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: A mixed methods exploratory study. SAGE Publishing.

Chicago Style (17th ed.) Citation

Melissa Basile, Jennifer Polo, Katherine Henthorne, Joan DeCelie-Germana, Susan Galvin, and Janice Wang. The Impact of Elexacaftor/tezacaftor/ivacaftor on Cystic Fibrosis Health-related Quality of Life and Decision-making About Daily Treatment Regimens: A Mixed Methods Exploratory Study. SAGE Publishing, 2024.

MLA (9th ed.) Citation

Melissa Basile, et al. The Impact of Elexacaftor/tezacaftor/ivacaftor on Cystic Fibrosis Health-related Quality of Life and Decision-making About Daily Treatment Regimens: A Mixed Methods Exploratory Study. SAGE Publishing, 2024.